Differentiating True NSTEMI from Troponin Elevation in Heart Failure

Diagnostic Approach

The European Society of Cardiology recommends demonstrating a dynamic rise and/or fall pattern in serial troponin measurements (≥20% change) combined with clinical evidence of myocardial ischemia to distinguish true NSTEMI from troponin elevation in heart failure 1, 2
Obtain troponin at presentation, 3-6 hours, and potentially 12-24 hours if initial values are normal but clinical suspicion remains high, as suggested by the American Heart Association 3, 4
A rising and/or falling pattern with at least one value above the 99th percentile strongly suggests NSTEMI rather than chronic troponin elevation from heart failure alone, according to the European Heart Journal 2, 5

Typical ischemic chest pain or anginal equivalent symptoms are indicative of true NSTEMI, as recommended by the European Society of Cardiology 1, 2
Troponin elevation >5-fold the upper reference limit (>90% positive predictive value for type 1 MI) is a strong indicator of NSTEMI, according to the American College of Cardiology 4, 5
Dynamic troponin changes with ≥20% relative change between serial measurements suggest NSTEMI, as suggested by the European Heart Journal 5

Perform emergency echocardiography to assess left ventricular ejection fraction, regional wall motion abnormalities, right ventricular function, valvular disease, and volume status, as recommended by the European Society of Cardiology 1
If troponin shows dynamic rise/fall pattern AND ischemic symptoms/ECG changes → manage as NSTEMI, according to the American Heart Association 4, 2

Manage NSTEMI according to guidelines with antiplatelet therapy, anticoagulation, and consideration for invasive strategy, as recommended by the European Society of Cardiology 1
Treat the underlying cause of non-ischemic troponin elevation (heart failure exacerbation, tachyarrhythmia, hypertensive emergency, etc.) according to disease-specific guidelines, as suggested by the European Heart Journal 1